Sankala Group’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

Sankala Group’s Portfolio LRND Stock Details LRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$38.6K	Hold	810	–	–	0.03%	264
2026 Q2	$37.5K	Buy	810 +240	+42%	+$10.3K	0.03%	275
2026 Q1	$20.8K	Sell	570 -7	-1%	-$277	0.02%	308
2025 Q4	$22.7K	Buy	+577	New	+$23.4K	0.02%	305

Other funds holding LRND

New York Life Investment Management New York $14.5B AUM 27.92% 1-Year Est. Return

Sankala Group's LRND Position: Q3 2026 in Review

Sankala Group held its New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) position steady in Q3 2026 at 810 shares worth $38.6K. The position accounts for 0.03% of the portfolio, ranked #264.

Sankala Group first reported a position in LRND in Q4 2025 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold LRND as of Q3 2026.

Sankala Group held 810 shares of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF worth $38.6K as of Q3 2026.
Sankala Group left its New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF share count unchanged in Q3 2026.
New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF made up 0.03% of Sankala Group's portfolio in Q3 2026, its #264 holding.
Sankala Group first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q4 2025 and has held it in 4 quarters since.
2 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.